Expanding the use of patient-reported outcomes (PROs): Screening youth with type 1 diabetes from underrepresented populations.


Journal

Journal of diabetes and its complications
ISSN: 1873-460X
Titre abrégé: J Diabetes Complications
Pays: United States
ID NLM: 9204583

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 07 10 2022
revised: 31 03 2023
accepted: 17 05 2023
medline: 12 6 2023
pubmed: 2 6 2023
entrez: 1 6 2023
Statut: ppublish

Résumé

Youth from lower socioeconomic status (SES) have suboptimal type 1 diabetes (T1D) outcomes. Patient reported outcomes (PROs) measure psychosocial states and are associated with T1D outcomes, however are understudied in low SES youth. We aimed to evaluate associations between PROs and public insurance status, a proxy for low SES. We analyzed survey data from 129 youth with T1D (age 15.7 ± 2.3 years, 33 % publicly insured) screened with PROMIS Global Health (PGH, measuring global health) and Patient Health Questionnaire (PHQ-9, measuring depressive symptoms) during diabetes appointments. Correlation and regression analyses evaluated differences in PGH and PHQ-9 by insurance status. For youth with public insurance, lower global health correlated with lower self-monitoring blood glucose (SMBG; r = 0.38,p = 0.033) and older age (r = -0.45,p = 0.005). In youth with private insurance, lower global health correlated with lower SMBG (r = 0.27,p = 0.018) and female sex (rho = 0.26,p = 0.015). For youth with private insurance, higher depressive symptoms correlated with higher body mass index (r = 0.22,p = 0.03) and fewer SMBG (r = -0.35,p = 0.04). In multivariate regression analyses, public insurance was inversely associated with global health (p = 0.027). PGH is a particularly salient PRO in youth with public insurance. Global health may be an important psychosocial factor to assess in youth with T1D from low SES backgrounds.

Identifiants

pubmed: 37263033
pii: S1056-8727(23)00112-5
doi: 10.1016/j.jdiacomp.2023.108514
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108514

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no relevant conflicts of interests.

Auteurs

Ananta Addala (A)

Stanford University, Division of Pediatric Endocrinology, Stanford, CA, United States; Stanford Diabetes Research Center, United States. Electronic address: aaddala@stanford.edu.

Jessie J Wong (JJ)

Stanford University, Division of Pediatric Endocrinology, Stanford, CA, United States.

Ricardo Medina Penaranda (RM)

Stanford University, Division of Pediatric Endocrinology, Stanford, CA, United States.

Sarah J Hanes (SJ)

Stanford University, Division of Pediatric Endocrinology, Stanford, CA, United States.

Hiba Abujaradeh (H)

University of Pittsburgh, School of Nursing, United States.

Rebecca N Adams (RN)

Stanford University, Division of Pediatric Endocrinology, Stanford, CA, United States.

Regan C Barley (RC)

Stanford University, Division of Pediatric Endocrinology, Stanford, CA, United States.

Esti Iturralde (E)

Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, United States.

Monica S Lanning (MS)

Stanford University, Division of Pediatric Endocrinology, Stanford, CA, United States.

Molly L Tanenbaum (ML)

Stanford Diabetes Research Center, United States; Stanford University School of Medicine, Department of Medicine, Division of Endocrinology, Gerontology, and Metabolism, United States.

Diana Naranjo (D)

Stanford University, Division of Pediatric Endocrinology, Stanford, CA, United States.

Korey K Hood (KK)

Stanford University, Division of Pediatric Endocrinology, Stanford, CA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH